Treponema pallidum DNA

LBC monolayer cytology + Pronatal 1G

Clinical significance

Cytology is a prophylactic examination that should be performed prophylactically, every year during a routine gynecological examination. Cyclic cytological examinations should begin after the age of 25, but not póź later than the age of 30. In the case of early initiation of cohabitation, cytology should be performed no more than 3 years after sexual initiation. In women 30 years of age and older whoóre not found to have lesions and whoóre found to have normal 3 consecutive cytology results, and in women after removal of the uterus including the cervix due to benign lesions, screening cytology can be performed every 3 years. In women infected with HIV, HPV type of high oncogenic risk, taking immunosuppressive drugs, treated in the past for mediastinal neoplasia (CIN2,CIN3) or cervical cancer, examinations should be performed at least once a year. Cytological examination over a period of more than 12 months should be performed in women whoóre not found to have cells from the transformation zone or endocervix in previous cytological smears, as well as in case of poor readability of previous smears due to inflammation, admixture of mucus or blood. The presence of certain characteristic chambersórek in the cytological examination can suggest infections with herpes virus, human papillomavirus, chlamydiosis, vitamin deficiencies, radiation lesions and the presence of an IUD. It also allows to assess the phase of the menstrual cycle and indirectly the secretion of sex hormonesów. It gives the opportunity to eliminate certain infections that affect the process of procreation, the course of pregnancy and the health of the newborn. The presence of coilocytesów suggests HPV infection, which allows you to expand the diagnosis and, if necessary, implement prevention of cervical cancer early enough. To rule out the presence of a genitourinary tract infection or accurately diagnose the cause of the infection, test with the UroGin Pronatal test. This poczwórny test is used specifically for the genetic diagnosis of the most common urogenital infections that pose the greatest risk to a pregnant woman and her baby before, during or after delivery. The test detects infections: - Chlamydia trachomatis (Chlamydiosis) - Mycoplasma hominis/genitalium (Mycoplasma) - Ureaplasma species (Ureaplasma) - HSV I/II (Herpes virus) It is estimated, that a few to several percent of pregnant women may be infected with herpes viruses (Herpes simplex types I and II), chlamydiosis (Chlamydia trachomatis parasites) and bacterial vaginosis (Ureaplasma species and Mycoplasma hominis bacteria). All untreated genitourinary infections, whether they produce symptoms or not, can lead bothóto chronic conditions and to very serious health complications.

Patient preparation

Material: -